SCHEMBL17303005

SCHEMBL17303005

CNC(CN=[N+]=[N-])CN=[N+]=[N-]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14002501 0.83 — —
SCHEMBL13997577 0.80 EPHX1 (0.31) —
SCHEMBL17154462 0.75 — —
SCHEMBL17303072 0.70 — —
SCHEMBL27951802 0.70 — —
SCHEMBL16203293 0.69 — —
SCHEMBL13881437 0.69 NEU4 (0.32) —
SCHEMBL18028046 0.69 NEU4 (0.32) —
SCHEMBL18028045 0.68 — —
SCHEMBL27592452 0.67 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2841437-B1 IMIDAZOTHIADIAZOLE AND IMIDAZOPYRAZINE DERIVATIVES AS PROTEASE ACTIVATED RECEPTOR 4 (PAR4) INHIBITORS FOR TREATING PLATELET AGGREGATION BRISTOL MYERS SQUIBB CO (US) 2017-07-05 — — EP disclosed
EP-2242742-B1 PYRIDINE DERIVATIVES NOVARTIS AG (CH) 2015-12-02 — — EP disclosed
Send feedback